Citigroup’s Allarity Therapeutics ALLR Stock Holding History

Citigroup’s Portfolio ALLR Stock Details ALLR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$18.5K	Buy	+17,616	New	+$22.1K	﹤0.01%	5024
2026 Q2	–	Sell	-7,766	Closed	-$8.46K	–	5701
2026 Q1	$8.46K	Buy	+7,766	New	+$8.36K	﹤0.01%	5099
2025 Q3	–	Sell	-1,472	Closed	-$1.49K	–	6065
2025 Q2	$1.49K	Buy	+1,472	New	+$1.39K	﹤0.01%	5380
2025 Q1	–	Sell	-12,294	Closed	-$14.4K	–	5545
2024 Q4	$14.4K	Buy	+12,294	New	+$16.3K	﹤0.01%	5318
2022 Q3	–	Hold	0	–	-$43K	–	5789
2022 Q2	–	Hold	0	–	–	–	4597
2022 Q1	–	Hold	0	–	–	–	5108

Other funds holding ALLR

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $96.6B AUM 22.52% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $50.1B AUM 35.17% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $273B AUM 15.34% 1-Year Est. Return

Citigroup's ALLR Position: Q3 2026 in Review

Citigroup opened a new position in Allarity Therapeutics (ALLR) in Q3 2026: 17,616 shares worth $18.5K. The stake represents ﹤0.01% of the portfolio and ranks #5024 among its holdings. This is a return to the name: Citigroup previously reported a position in ALLR as recently as Q1 2026.

Citigroup first reported a position in ALLR in Q4 2024 and has held it in 4 quarters since. 11 funds tracked by Wall St. Rank hold ALLR as of Q3 2026.

Citigroup held 17,616 shares of Allarity Therapeutics worth $18.5K as of Q3 2026.
Allarity Therapeutics was a new Citigroup position in Q3 2026.
Allarity Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5024 holding.
Citigroup first reported a position in Allarity Therapeutics in Q4 2024 and has held it in 4 quarters since.
11 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.